ACCENDRA HEALTH INC/VA/

ACH

ACCENDRA HEALTH INC/VA/

ACH

Insider Sentiment (TTM):

Last Purchase:2025-08-14Last Sale:2024-11-21Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:61,728,816Shares Outstanding:76,432,000Institutional Ownership Pct.:80.76%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	8	337	282	33	38	59	28	45	244	245	243	215
Accounts And Notes Receivable Net	120	104	96	203	196	580	218	662	662	670	598	683
Assets Current
Assets Current	271	589	548	2,132	2,299	2,206	2,021	2,117	2,327	2,236	2,103	2,130
Inventory Net	73	65	74	64	69	1,409	68	1,242	1,231	1,145	1,111	1,084
Other Assets Current	70	83	96	68	104	158	82	167	190	177	151	148
Assets Of Disposal Group Including Discontinued Op…	-	-	-	1,764	1,891	-	1,625	-	-	-	-	-
Property Plant And Equipment And Finance Lease Rig…	-	-	-	-	-	520	509	499	493	501	544	540
Property Plant And Equipment Net	209	228	256	260	259	-	249	-	-	-	-	-
Operating Lease Right Of Use Asset	97	102	109	119	120	383	127	357	368	350	297	300
Goodwill	1,228	1,228	1,228	1,228	1,228	1,332	1,228	1,642	1,635	1,635	1,639	1,635
Intangible Assets Net Excluding Goodwill	78	107	136	166	195	285	210	313	326	343	362	382
Other Assets Noncurrent	224	162	174	132	53	130	90	153	154	142	149	137
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	-	731	-	-	-	-	-
Assets	2,107	2,416	2,452	4,036	4,155	4,856	4,656	5,081	5,304	5,208	5,093	5,124
Liabilities And Stockhold…
Accounts Payable Current	353	375	364	340	357	1,381	360	1,338	1,382	1,219	1,172	1,182
Employee Related Liabilities Current	42	33	69	45	53	87	74	100	108	79	116	106
Liabilities Current
Liabilities Current	666	1,203	947	2,466	2,675	1,960	1,852	1,934	2,131	1,933	1,892	1,732
Long Term Debt Current	0	581	250	280	383	50	43	43	211	208	207	-
Other Liabilities Current	272	214	264	455	422	442	295	454	430	427	397	444
Liabilities Of Disposal Group Including Discontinu…	-	-	-	1,346	1,460	-	1,081	-	-	-	-	-
Long Term Debt And Capital Lease Obligations	1,718	1,522	1,800	1,835	1,595	1,898	1,798	1,842	1,872	1,946	1,891	2,114
Operating Lease Liability Noncurrent	63	67	70	81	81	324	89	288	298	276	222	225
Deferred Income Tax Liabilities Net	-	-	-	-	0	16	19	26	29	34	42	46
Other Liabilities Noncurrent	211	88	95	83	85	87	73	116	114	123	123	121
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	238	-	-	-	-	-
Liabilities	2,658	2,881	2,913	4,466	4,436	4,285	4,070	4,207	4,443	4,313	4,169	4,237
Common Stock Value	154	153	153	155	154	154	154	154	154	153	153	153
Additional Paid In Capital Common Stock	472	469	467	468	467	460	454	446	440	439	434	428
Stockholders Equity	-551	-465	-461	-430	-281	571	586	896	882	916	924	887
Retained Earnings Accumulated Deficit	-1,175	-1,086	-1,080	-1,022	-872	1	27	302	315	347	369	351
Accumulated Other Comprehensive Income Loss Net Of…	-1	-1	-1	-30	-30	-44	-49	-27	-49	-43	-32	-45
Liabilities And Stockholders Equity	2,107	2,416	2,452	4,036	4,155	4,856	4,656	5,081	5,304	5,208	5,093	5,124
Allowance For Doubtful Accounts Receivable Current	-	-	-	-	-	6	6	6	8	7	8	9
Accumulated Depreciation Depletion And Amortizatio…	196	181	-	-	194	582	-	570	561	546	-	532
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	-	-	85
Common Stock Par Or Stated Value Per Share	2	2	2	2	2	2	2	2	2	2	2	2
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	77	77	76	77	77	77	77	77	77	76	77	76
Shares Outstanding	77	77	76	77	77	77	77	77	77	76	77	76

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-30.59%	-7.71%	-20.57%	-	-	-	-	-	-	-	-	-
2025	-5.58%	26.90%	12.73%	21.38%	2.81%	-14.25%	-32.24%	-28.46%	-36.52%	-8.81%	7.66%	37.16%
2024	-3.73%	-6.81%	-18.62%	1.05%	-1.98%	-13.52%	12.25%	7.92%	24.50%	-6.05%	-27.66%	-22.96%
2023	-	-	-	-	-	-	-4.06%	1.27%	-5.23%	18.25%	18.76%	-13.51%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.41	0.49	0.58	0.86	0.86	1.13	1.09	1.09	1.09	1.16	1.11	1.23
Quick Ratio	0.30	0.43	0.50	0.84	0.83	0.41	1.05	0.45	0.51	0.56	0.52	0.60
Working Capital	-394.77M	-614.60M	-399.20M	-334.29M	-376.01M	245.98M	168.97M	182.37M	195.89M	303.25M	210.91M	398.09M
Leverage & Debt
Debt to Equity	-4.83	-6.20	-6.32	-10.40	-15.78	7.51	6.94	4.70	5.04	4.71	4.51	4.78
Interest Coverage TTM	0.26	0.23	0.26	-2.53	-2.49	-1.96	-2.02	0.93	0.81	0.69	0.66	-0.06
Debt Ratio	1.26	1.19	1.19	1.11	1.07	0.88	0.87	0.83	0.84	0.83	0.82	0.83
Efficiency & Turnover
Asset Turnover TTM	0.85	0.75	0.78	0.17	0.16	0.15	0.55	1.30	1.61	1.98	1.97	1.92
Per Share Metrics
Diluted EPS TTM	-3.94	-14.16	-14.31	-17.34	-15.64	-4.73	-4.73	-0.62	-0.55	-0.51	-0.53	-1.54
Free Cash Flow Per Share TTM	-4.89	-4.86	-4.69	-7.70	-4.92	-3.71	-3.97	0.05	1.88	4.44	7.26	6.91
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	44.83%	45.95%	54.17%	226.65%	260.88%	298.07%	82.80%	33.39%	25.68%	20.75%	20.56%	19.18%
Operating Profit Margin TTM	1.11%	0.91%	0.99%	-34.77%	-34.64%	-28.01%	-8.12%	1.78%	1.30%	1.00%	1.01%	-0.09%
Net Profit Margin TTM	-11.41%	-39.84%	-39.85%	-173.35%	-157.69%	-49.34%	-13.53%	-0.74%	-0.50%	-0.37%	-0.40%	-1.14%
Growth Metrics
Net Revenue Growth (1Y)	247.03%	266.37%	3.06%	-88.31%	-91.05%	-92.89%	-74.07%	-35.32%	-15.92%	3.50%	3.80%	3.62%
Net Income Growth (1Y)	-74.88%	195.84%	203.47%	2,647.63%	2,734.35%	843.49%	778.15%	-58.33%	-56.76%	-6.15%	-284.47%	-195.69%
EPS Growth (1Y)	-74.80%	199.09%	202.85%	2,640.59%	2,726.69%	831.85%	767.21%	-58.81%	-57.28%	-7.55%	-281.33%	-194.06%
Calculated Values
Free Cash Flow TTM	-375.30M	-371.80M	-360.93M	-595.12M	-378.53M	-286.75M	-304.85M	3.84M	143.89M	338.63M	549.84M	526.61M
Net Debt	1.71B	1.77B	1.77B	2.08B	1.94B	1.89B	1.81B	1.81B	1.81B	1.88B	1.82B	1.86B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-08-14Purchase

Owner: Coliseum, Capital Partner…

Title: -

Shares: 492,852

Price/Share: $5.31

Value: $2,617,044.12

Shares Owned: 13,100,807

Relationship: TenPercentOwner

Ownership: Indirect

2025-04-10Purchase

Owner: Coliseum, Capital, Llc, S…

Title: -

Shares: 80,000

Price/Share: $7.19

Value: $575,200.00

Shares Owned: 11,562,955

Relationship: TenPercentOwner

Ownership: Indirect

2025-04-07Purchase

Owner: Coliseum, Capital Managem…

Title: -

Shares: 240,000

Price/Share: $7.84

Value: $1,881,600.00

Shares Owned: 11,152,955

Relationship: TenPercentOwner

Ownership: Indirect

2025-03-04Purchase

Owner: Shackelton, Christopher S…

Title: -

Shares: 800,000

Price/Share: $9.75

Value: $7,800,000.00

Shares Owned: 10,624,599

Relationship: TenPercentOwner

Ownership: Indirect

2024-11-21Sale

Owner: Leon, Jonathan A

Title: EVP, Chief Financial Officer

Shares: 5,282

Price/Share: $11.82

Value: $62,433.24

Shares Owned: 130,822

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-08-14	Coliseum, Capital Partner…	TenPercentOwner	-	Indirect	Purchase	492,852	5.31	$2,617,044.12	13,100,807	4
2025-04-10	Coliseum, Capital, Llc, S…	TenPercentOwner	-	Indirect	Purchase	80,000	7.19	$575,200.00	11,562,955	4
2025-04-07	Coliseum, Capital Managem…	TenPercentOwner	-	Indirect	Purchase	240,000	7.84	$1,881,600.00	11,152,955	4
2025-03-04	Shackelton, Christopher S…	TenPercentOwner	-	Indirect	Purchase	800,000	9.75	$7,800,000.00	10,624,599	4
2024-11-21	Leon, Jonathan A	Officer	EVP, Chief Financial Officer	Direct	Sale	5,282	11.82	$62,433.24	130,822	4
2024-11-18	Sarkar, Snehashish	Other	-	Direct	Sale	2,055	12.26	$25,194.30	55,886	4
2024-08-22	Leon, Jonathan A	Officer	SVP, Corp Treasurer, Intm CFO	Direct	Sale	7,500	15.83	$118,725.00	93,171	4
2024-06-06	Bernocchi, Perry A	Officer	EVP, CEO,. Patient Direct	Direct	Sale	20,015	17.48	$349,862.20	129,520	4
2024-06-05	Beck, Mark A	Director	-	Direct	Sale	9,344	17.25	$161,184.00	11,154	4
2024-06-04	Sarkar, Snehashish	Officer	EVP, Chief Information Officer	Direct	Sale	9,980	17.32	$172,853.60	59,137	4
2024-06-03	Bruni, Alexander J	Officer	EVP, CFO	Direct	Sale	10,568	17.76	$187,687.68	49,950	4
2024-05-17	Galloway, Heath H	Officer	EVP,General Counsel & CorpSecy	Direct	Sale	2,052	19.06	$39,111.12	54,846	4
2024-05-01	Bernocchi, Perry A	Officer	EVP, CEO,. Patient Direct	Direct	Sale	24,094	24.40	$587,893.60	170,497	4
2024-04-22	Leon, Jonathan A	Officer	SVP, Corporate Treasurer	Direct	Sale	5,000	24.84	$124,200.00	84,673	4
2024-02-27	Lowry, Michael Wayne	Officer	SVP, Corporate Controller	Direct	Sale	10,000	25.00	$250,000.00	71,654	4
2024-02-20	Leon, Jonathan A	Officer	SVP, Corporate Treasurer	Direct	Sale	5,000	22.00	$110,000.00	75,713	4
2024-02-07	Galloway, Heath H	Officer	EVP,General Counsel & CorpSecy	Direct	Sale	97	19.91	$1,931.27	36,437	4
2024-01-17	Leon, Jonathan A	Officer	SVP, Corporate Treasurer	Direct	Sale	7,500	18.08	$135,600.00	83,213	4
2023-12-20	Leon, Jonathan A	Officer	SVP, Corporate Treasurer	Direct	Sale	5,000	21.34	$106,700.00	93,213	4
2023-11-22	Bernocchi, Perry A	Officer	EVP, CEO,. Patient Direct	Direct	Sale	19,302	18.75	$361,912.50	164,347	4
2023-11-20	Leon, Jonathan A	Officer	SVP, Corporate Treasurer	Direct	Sale	5,000	18.62	$93,100.00	98,213	4
2023-11-10	Bruni, Alexander J	Officer	EVP, CFO	Direct	Sale	12,668	17.57	$222,576.76	41,457	4
2023-11-10	Galloway, Heath H	Officer	EVP,General Counsel & CorpSecy	Direct	Sale	5,500	17.57	$96,635.00	36,479	4
2023-06-16	Pesicka, Edward A	Director,Officer	President & CEO	Direct	Sale	38,780	19.28	$747,678.40	708,373	4
2023-06-09	Pesicka, Edward A	Director,Officer	President & CEO	Direct	Sale	118,928	20.79	$2,472,513.12	785,933	4
2023-06-07	Pesicka, Edward A	Director,Officer	President & CEO	Direct	Sale	118,927	21.56	$2,564,066.12	1,023,789	4
2023-06-06	Lowry, Michael Wayne	Officer	SVP, Corporate Controller	Direct	Sale	10,000	21.11	$211,100.00	80,360	4
2023-03-22	Leon, Jonathan A	Officer	SVP, Corporate Treasurer	Direct	Sale	6,000	13.50	$81,000.00	106,723	4
2022-10-17	Henkel, Robert J	Director	-	Direct	Purchase	1,000	15.68	$15,680.00	28,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

80.76%

Inst. Shares: 61,728,816

Shares Outstanding: 76,432,000

2025-12-31

87.94%

Inst. Shares: 67,622,240

Shares Outstanding: 76,897,000

2025-09-30

92.03%

Inst. Shares: 71,126,161

Shares Outstanding: 77,288,000

2025-06-30

95.30%

Inst. Shares: 73,316,779

Shares Outstanding: 76,935,000

2025-03-31

94.09%

Inst. Shares: 72,707,123

Shares Outstanding: 77,272,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	61,728,816	76,432,000	80.76%
2025-12-31	67,622,240	76,897,000	87.94%
2025-09-30	71,126,161	77,288,000	92.03%
2025-06-30	73,316,779	76,935,000	95.30%
2025-03-31	72,707,123	77,272,000	94.09%
2024-12-31	74,744,642	76,741,000	97.40%
2024-09-30	74,944,634	77,090,000	97.22%
2024-06-30	75,423,414	76,727,000	98.30%
2024-03-31	74,497,121	76,319,000	97.61%
2023-12-31	75,491,787	75,785,000	99.61%
2023-09-30	78,661,208	76,203,000	103.23%
2023-06-30	71,748,986	75,801,000	94.65%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ACCENDRA HEALTH INC/VA/ (ACH) — SEC Financial Statements & Analysis

ACCENDRA HEALTH INC/VA/ (ACH) is a wholesale-medical, dental & hospital equipment & supplies company, incorporated in VA. ACCENDRA HEALTH INC/VA/ trades on NYSE as: ACH. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ACCENDRA HEALTH INC/VA/ reported a 247.03% year-over-year revenue growth, a Gross Profit Margin of 44.83% (TTM), a Debt-to-Equity ratio of -4.83x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 247.03%
Gross Profit Margin TTM: 44.83%
Debt To Equity: -4.83x

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ACCENDRA HEALTH INC/VA/ in?

ACCENDRA HEALTH INC/VA/ (ACH) operates in the Wholesale-Medical, Dental & Hospital Equipment & Supplies industry.

What exchange does ACH trade on?

ACCENDRA HEALTH INC/VA/ (ACH) trades on the NYSE.

Where is ACCENDRA HEALTH INC/VA/ incorporated?

ACCENDRA HEALTH INC/VA/ is incorporated in VA.